Insider Trading & Ownership - Foresite Capital Management IV LLC

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Foresite Capital Management IV LLC
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-05-08
Purchase
2023-05-10
5:42 pm
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
10% Owner
1,780,000$2.8$4,984,00010,192,354
(Indirect)
View
2020-02-27
Sale
2020-03-02
5:01 pm
AERIE PHARMACEUTICALS INCAERIForesite Capital Management II LLC
Foresite Capital Fund II L.P.
Foresite Capital Fund III L.P.
Foresite Capital Fund IV L.P.
Foresite Capital Management III LLC
Foresite Capital Management IV LLC
Tananbaum James B.
10% Owner
1,000,000$17.07$17,070,0001,229,633
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-04-03
Disposition
2024-04-05
2:15 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
13,718,311$00
(Indirect)
View
2023-02-17
Other
2023-02-22
2:49 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
10% Owner
1,100,000$013,038,311
(Indirect)
View
2021-11-01
Other
2021-11-03
4:17 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSForesite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Tananbaum James B.
10% Owner
1,963,180$06,628,733
(Indirect)
View

Ownership
2021-02-10
6:00 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSForesite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Tananbaum James B.
10% Owner
0$06,612,181
(Indirect)
View
2020-12-07
Conversion
2020-12-09
1:35 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
19,675,448$0291,667
(Indirect)
View
2020-12-03
Option Award
2020-12-04
8:57 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
1,000,000$20125,000
(Indirect)
View

Ownership
2020-12-03
06:03 am
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
0$09,838,311
(Indirect)
View